lnc-MRGPRF-6:1 Promotes ox-LDL-Induced Macrophage Ferroptosis via Suppressing GPX4
Table 2
Clinical and biochemical characteristics of patients with coronary artery disease (CAD) and controls.
CAD (n = 20)
Control (n = 20)
Gender (male)
13 (65%)
12 (60%)
Age (years)
64.35 ± 8.16
60.25 ± 7.87
Smoking
13 (65%)
12 (60%)
Drinking
14 (70%)
12 (60%)
BMI (kg/m2)
25.64 ± 3.37
25.27 ± 4.03
Hypertension
15 (75%)
13 (65%)
Diabetes
7 (35%)
6 (30%)
WBC (109/L)
6.2 ± 1.72
6.50 ± 1.39
Hemoglobin (g/L)
130.45 ± 10.96
127.7 ± 18.60
Platelet (109/L)
173.75 ± 47.63
205.65 ± 48.74
ACEI/ARB
6 (30%)
5 (25%)
β-Blocker
5 (25%)
3 (15%)
CCB
10 (50%)
12 (60%)
Statin
5 (25%)
4 (20%)
Aspirin
5 (25%)
3 (15%)
Clopidogrel
5 (25%)
1 (5%)
Warfarin
5 (25%)
1 (5%)
Note: Categorical data presented as number of total, n (%). ,. BMI, body mass index; WBC, white blood cell; ACEI/ARB, angiotensin-converting enzyme inhibitor, angiotensin receptor antagonist; CCB, calcium channel blocker.
